Drugs that make HIV-infected cells self-destruct induce profound viral load drops in mice after just one or two doses
Young adults with HIV have high prevalence of heart disease risk factors
Why is the roll-out of injectable PrEP taking so long?
Weight gain on HIV treatment: more than a 'return to health' phenomenon?
The US opioid crisis has reached older people with HIV
Adolescents prefer long-acting injectables to daily oral HIV treatment, study finds
Almost two-thirds of new HIV cases occur outside southern and eastern Africa
Top 5 stories on HIV in the US from CROI 2024
People who inject drugs in the US are more aware of PrEP, but aren’t taking it
Top 5 stories on injectable HIV treatment and PrEP from CROI 2024
Over 30 years, big fall in HIV among people who inject drugs in Baltimore, but hepatitis C remains high
Top 5 stories on HIV and women from CROI 2024
Top 5 HIV PrEP stories from CROI 2024
Long-acting injectables can be a good option for people with adherence challenges
Top 5 stories on co-morbidities affecting people with HIV from CROI 2024
Should event-driven PrEP be an option for women?
Nearly two million people in sub-Saharan Africa may have advanced HIV disease
Top 5 HIV treatment stories from CROI 2024
